Echo IQ has secured firm commitments to raise approximately $110 million through an institutional share placement. The placement shares are priced at $1.45 each, representing an 8.8% discount to the ...

The Australian Competition and Consumer Commission has blocked Coles from acquiring a leasehold interest for a new supermarket and liquor site in Kalgoorlie-Boulder. The regulatory block prevents the ...

BioAge Labs (NASDAQ:BIOA) today reported its financial results for the full year ended December 31, 2025, marking a pivotal transition from early-stage discovery to a high-conviction clinical platform ...

AstraZeneca (NASDAQ:AZN) unveiled positive data from its late-stage EMERALD-3 clinical trial on Monday, demonstrating that adding its dual-immunotherapy regimen to standard localized therapy ...

Coinbase will cut about 14% of its workforce, or roughly 700 jobs, as it restructures operations amid a market downturn and a shift toward artificial intelligence. CEO Brian Armstrong said the company ...

IREN has finalized the buyout of Ingenostrum, S.L. (Nostrum Group), establishing its first operational footprint in Europe. The transaction absorbs 490MW of secured, grid-connected power capacity in ...

Atlantic Lithium Limited (ASX:A11) has announced the successful parliamentary ratification of the Mining Lease for its flagship Ewoyaa Lithium Project, marking a key milestone for Ghana’s emerging ...

Texas Instruments (NASDAQ:TXN) reported its financial results for the first quarter of 2026, signaling a significant recovery in the semiconductor sector. The Dallas-based chipmaker achieved revenue ...

Team USA's run in the World Cup came to an end on Monday as it failed to make the quarterfinals, while outrage over FIFA's decision to allow striker Folarin Balogun to play continued to simmer.

Alphabet's Google (NASDAQ:GOOGL) has placed an order with Intel (NASDAQ:INTC) to manufacture more than 3 million of its custom artificial intelligence processors in 2028, according to a report from ...

Hims & Hers (NYSE:HIMS) posted first-quarter revenue of $608.1 million, a 4% increase compared to $586 million in the prior-year period. However, the company’s gross margin fell to 65% from 73% a year ...

Ascentage Pharma (NASDAQ:AAPG) announced that abstracts for six of its clinical studies have been published ahead of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, outlining ...